ClinicalTrials.gg

What’s New Sign In

Biological

Therapeutic Allogeneic Lymphocytes clinical trials

studies test it: 25
open now: 0
in phase 3: 1
first study started: 1998

How studies write it

Studies that test it under each name

Name

therapeutic allogeneic lymphocytes: 24
ALLOLYMPH: 4
Allogeneic Lymphocytes: 3

Studies by the year they started

25 studies that test it; most in 2002 (5)

By phase

A phase 1/2 study counts in both.

Phase 1: 8
Phase 2: 19
Phase 3: 1
No phase: 1

What it is tested for

Each study’s main condition, where its own words name it.

Lymphoma: 5
Leukemia: 4
Carcinoma, Renal Cell: 3
Burkitt Lymphoma: 2
Lymphoproliferative Disorders: 1
Anemia, Aplastic: 1
Multiple Myeloma: 1
Lymphoma, Non-Hodgkin: 1
Kidney Neoplasms: 1
Sarcoma: 1
Melanoma: 1
Recurrence: 1

Who runs them

Industry 0 · Other 25

Fred Hutchinson Cancer Center (3) · Robert Lowsky (2) · University of Chicago (2) · Alliance for Clinical Trials in Oncology (2) · University of California, San Francisco (2) · Rutgers, The State University of New Jersey (2) · University of Edinburgh (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Often tested with

Tested in the same studies.

Fludarabine (12) · Fludarabine phosphate (11) · Cyclophosphamide (7) · Tacrolimus (7) · Busulfan (4) · Mycophenolic Acid (4) · Antilymphocyte Serum (4) · Methotrexate (4)

Studies

Open first, then newest update. How each study uses Therapeutic Allogeneic Lymphocytes is read from its arms, and is right about nine times in ten.

Testing it · 25

See all 25 studies that test Therapeutic Allogeneic Lymphocytes →

Given in every arm · 15 — Therapeutic Allogeneic Lymphocytes is usual care beside what is tested